A contraceptive subdermal implant releasing the progestin ST-1435: ovarian function, bleeding patterns, and side effects

Long-Acting Contraceptive Delivery Systems

Gerald I. Zatuchni · Studies in Family Planning · 1985 · 280 citations

Medicine, Gynecology, Obstetrics +15

Oral contraceptives and lipoprotein metabolism.

Minna Tikkanen, Esko A. Nikkilä · PubMed · 1986 · 45 citations

Medicine, Endocrinology, Obstetrics +17

Contraception with subcutaneous capsules containing ST-1435. Pituitary and ovarian function and plasma levels of ST-1435

Lähteenmäki Pekka, Erik Weiner, Lähteenmäki Pertti et al. · Contraception · 1981 · 42 citations

Medicine, Endocrinology, Gynecology +16

A contraceptive vaginal ring releasing ethinyl estradiol and the progestin ST-1435: Bleeding control, serum steroid concentrations, serum lipids and serum chemistry

Marjut Laurikka-Routti, Maija Haukkamaa, Oskari Heikinheimo · Contraception · 1990 · 36 citations

Medicine, Endocrinology, Pharmacology +17

Contraception with subdermal implants releasing the progestin ST-1435: A dose-finding study

Maija Haukkamaa, Marjut Laurikka-Routti, Oskari Heikinheimo et al. · Contraception · 1992 · 34 citations

Medicine, Gynecology, Obstetrics +13